Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic drug monitoring intervention and economic evaluation for voriconazole
ChiCTR2400082731Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Apr 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of voriconazole in pulmonary aspergillosis (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: 5-level EQ-5D version (EQ-5D-5L), Cost and 1 more. Planned start Apr 2024; status: not yet recruiting.
02
Drugs
voriconazole
03
Conditions
pulmonary aspergillosis
Beyond the preview
Go deeper on ChiCTR2400082731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400082731.